Tirzepatide 60 mg One Vial

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is designed to improve blood sugar regulation and support weight management by enhancing insulin secretion, reducing glucagon release, and slowing gastric emptying. This dual action promotes improved glycemic control while reducing appetite and promoting satiety.

The 60 mg vial is prepared for subcutaneous injection and is typically prescribed as part of a comprehensive treatment plan for type 2 diabetes and weight management, under the guidance of a healthcare professional.